Diagnostics companies at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

55 diagnostics companies are at SABCS 2026 — 50 presentations on the program and 27 with a booth in the exhibit hall. Most represented: Myriad Genetics (5 on the program), Caris Life Sciences (2 on the program), Inocras (1 on the program). 29 of them have their own page in this guide. As of Nov 10, 2026.

All 956 organizations at SABCS 2026 →

Focus
Top represented
Showing 1–14 of 55 organizations
OrganizationSABCS 2026 Attendance
Myriad Genetics
Salt Lake City, UT
Diagnostics
Molecular diagnostics company offering hereditary cancer risk tests, tumor tests that guide treatment, and women's health and pharmacogenomic screening.
Booth
Exhibiting at Booth 215
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
12:30–2pm
Evaluating Clinically Actionable Somatic and Germline Mutations in Black and NonHispanic White Women with Breast Cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Ultrasensitive MRD testing in breast cancer shows neoadjuvant therapy reduces ctDNA beyond changes in tumor burden
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Diagnostics
Molecular profiling company whose tissue and blood tests, backed by AI, map a tumor's DNA, RNA and proteins to guide cancer treatment.
Booth
Exhibiting at Booth 1215
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
12:30–2pm
Patient-tissue proteogenomics identifies a novel cell-surface tumor antigen as a treatment-retained ADC target in breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Thu Dec 10
5–6:30pm
Development of a multi-biomarker predictor of CDK4/6 inhibitor benefit in metastatic breast cancer
Exhibit Hall
Breast Cancer: Metastatic - Hormone Receptor Positive
Inocras
San Diego, CA
Diagnostics
Whole-genome sequencing company using its own analytics to turn genome data into clinical and research insights for precision health.
Booth
Exhibiting at Booth 247
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
12:30–2pm
Utility of Whole Genome Sequencing in TNBC Expanding Actionability via Whole Genome Resolution
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
12:30–2pm
Utility of Whole Genome Sequencing in HR+ HER2− Breast Cancer: Unveiling Endocrine-Related and Kinase-Pathway Alterations Beyond the Exome
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
NeoGenomics
Fort Myers, FL
Diagnostics
Cancer diagnostics company running CLIA-certified labs that offer a broad oncology testing menu to oncologists, pathologists, hospitals and drug developers.
Booth
Exhibiting at Booth 242
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
5–6:30pm
Stage specific molecular evolution across early-stage and metastatic triple-negative breast cancer
Exhibit Hall
Real-World Data and Real-World Evidence
Tempus
Chicago, IL
Diagnostics
AI-driven precision medicine company offering genomic testing and data tools to physicians and helping drug developers with discovery and trials.
Booth
Exhibiting at Booth 1332
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
12:30–2pm
Her2 rna outperforms ihc in predicting outcomes to t-dxd
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Fri Dec 11
12:30–2pm
Whole-genome sequencing reveals distinctive chromosome 17 copy number and structural variant landscapes in breast cancer tissue samples
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
ARTIDIS
Basel, Switzerland
Diagnostics
Nanotechnology-based analysis of biopsy tissue, paired with a data platform, to help guide treatment of solid tumors.
Booth
Exhibiting at Booth 849
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Astrin Biosciences
Saint Paul, MN
Diagnostics
Early cancer detection company whose Certitude blood test is designed to help find breast cancer early.
Booth
Exhibiting at Booth 1534
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
5–6:30pm
Natera
San Carlos, CA
Diagnostics
Cell-free DNA blood tests for cancer: tumor-informed MRD monitoring with Signatera, treatment response, genomic profiling and hereditary risk.
Booth
Exhibiting at Booth 909
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
12:30–2pm
Assay performance and longitudinal quantification using a tissue-free, molecular residual disease assay in breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
PreludeDx
Laguna Hills, CA
Diagnostics
Genomic tests that help decide on surgery and radiation: DCISionRT in DCIS and AidaBreast in early invasive breast cancer.
Booth
Exhibiting at Booth 1208
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Agendia
Irvine, CA
Diagnostics
Genomic tests for early-stage breast cancer, including MammaPrint and BluePrint, that help clinicians weigh recurrence risk and choose treatment.
Booth
Exhibiting at Booth 1242
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Artera
Los Altos, CA
Diagnostics
Multimodal AI tests that read digitized pathology slides alongside clinical data to judge how aggressive a cancer is and who benefits from therapy.
Booth
Exhibiting at Booth 1544
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Ataraxis
New York, NY
Diagnostics
AI tests that read routine pathology slides and patient data to estimate outcomes and guide treatment in every subtype of invasive breast cancer.
Booth
Exhibiting at Booth 1524
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Diagnostics
Asuragen molecular diagnostic kits and software, including the QuantideX line for cancer monitoring and diagnosis, run on widely installed lab instruments.
Booth
Exhibiting at Booth 1430
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Biovica
Uppsala, Sweden
Diagnostics
Maker of DiviTum TKa, a blood test of tumor cell growth that tracks treatment response in metastatic hormone receptor-positive breast cancer.
Booth
Exhibiting at Booth 1252
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from diagnostics companies

Tell us what you sell and we’ll find the people at these diagnostics companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SABCS 2026 by

Exhibit hall

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction